Common use of Purchase Warrants Clause in Contracts

Purchase Warrants. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date an option (“Representative’s Warrants”) to purchase a number of shares of Common Stock equal to 4% of the number of the Firm Shares and Option Shares, if any, issued in the Offering, pursuant to a warrant in the form attached hereto as Exhibit A, at an initial exercise price equal to 120% of the price per share of the shares of Common Stock sold in the Offering. The Representative’s Warrants and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative’s Warrants and the underlying shares of Common Stock during the one hundred eighty (180) days beginning on the date of commencement of sales of the offering and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge, or hypothecate the Representative’s Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days beginning on the date of commencement of sales of offering, other than as permitted by FINRA Rule 5110(e)(2).

Purchase Warrants. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date an option (“Representative’s Warrants”) to as applicable, five-year warrants (which are stock acquisition rights under Japanese laws) for the purchase of a number of shares of Common Stock ADSs equal to 43% of the number of the Firm Shares and Option Shares, if any, issued in the Offering, pursuant to a warrant in the form attached hereto as Exhibit A, at an initial exercise price equal to 120125% of the price per share of the shares of Common Stock ADSs sold in the Offering. The Representative’s Warrants and the shares of Common Stock ADSs issuable upon exercise thereof are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representative’s Warrants and the underlying shares of Common Stock ADSs during the one hundred eighty (180) days beginning on after the date of commencement of sales of the offering Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge, or hypothecate the Representative’s Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days beginning on following the date of commencement of sales of offering, Effective Date other than as permitted by FINRA Rule 5110(e)(2).

Purchase Warrants. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date an option (“Representative’s Warrants”) to ), five-year warrants for the purchase of a number of shares of Common Stock the Shares equal to 47% of the number of the Firm Shares and Option Shares, if any, issued in the Offering, pursuant to a warrant in the form attached hereto as Exhibit A, at an initial exercise price equal to 120of $[*] (or 100% of the public offering price per share of the shares of Common Stock sold in the OfferingFirm Share). The Representative’s Warrants and the shares of Common Stock Shares issuable upon exercise thereof are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 of the Financial Industry Regulatory Authority, Inc. (“FINRA”) against transferring the Representative’s Warrants and the underlying shares of Common Stock Shares during the one hundred eighty (180) days beginning on after the date of commencement of sales of in the offering Offering and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge, pledge or hypothecate the Representative’s Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days beginning on following the date of commencement of sales of offering, in the Offering other than as permitted by FINRA Rule 5110(e)(2).

Purchase Warrants. The Company hereby agrees to issue and sell to the Representative (and/or its designees) on the Closing Date an option (“Representative’s Warrants”) to ), five-year warrants for the purchase of a number of shares of Common Stock the Shares equal to 47% of the number of the Firm Shares and Option Shares, if any, issued in the Offering, pursuant to a warrant in the form attached hereto as Exhibit A, at an initial exercise price equal to 120of $6.75 (or 135% of the public offering price per share of the shares of Common Stock sold in the OfferingFirm Share). The Representative’s Warrants and the shares of Common Stock Shares issuable upon exercise thereof are hereinafter referred to together as the “Representative’s Securities.” The Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 of the Financial Industry Regulatory Authority, Inc. (“FINRA”) against transferring the Representative’s Warrants and the underlying shares of Common Stock Shares during the one hundred eighty (180) days beginning on after the date of commencement of sales of in the offering Offering and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge, pledge or hypothecate the Representative’s Warrants, or any portion thereof, or be the subject of any hedging, short sale, derivative, put, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days beginning on following the date of commencement of sales of offering, in the Offering other than as permitted by FINRA Rule 5110(e)(2).